Supplement GMP Violations Stop Mexican Firm’s Herbal Imports
This article was originally published in The Tan Sheet
U.S. supplement manufacturers and marketers generally continue distributing products after FDA notes GMP problems at their facilities, but Herbolaris Internacional is not reaching customers in the U.S. since the agency posted an import alert on its products in December.
You may also be interested in...
Dietary ingredients identified in recent FDA warning letters as linked to disease claims by marketers directing customers to scientific literature include omega-3 fatty acid, ginkgo biloba, glucosamine curcumin and vitamin D.
Approvals by FDA also include revised container and consumer information labeling for J&J's Men’s Rogaine to align with labeling for Women’s Rogaine; bonus-pack labeling for Bayer AG’s Aleve; and
During JP Morgan conference, Alex Gorsky suggests responding to pandemic is changing health care, including businesses providing pharmaceuticals, medical technologies, nutritionals and other necessary products.